Georgia Vogelsang

This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles free of charge to researchers worldwide.

Research Profile (preview)

Disorders

Procedures

Chemicals & Drugs

Concepts & Ideas

Living Beings

Rats
Infant

Sign-in to see full Profile

Sign-in to see all Coauthors

Publications

TOP 3
Vogelsang Georgia B
Magic bullet, part III?
Griffith Linda M; Pavletic Steven Z; Lee Stephanie J; Martin Paul J; Schultz Kirk R; Vogelsang Georgia B
Chronic Graft-versus-Host Disease--implementation of the National Institutes of Health Consensus Criteria for Clinical Trials.
Bolaños-Meade Javier; Vogelsang Georgia B
Chronic graft-versus-host disease.

Sign-in to see all Publications

Sign in free and see...

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the visualized research activity
of experts around the globe

Sign-in to see more

Geonetwork of Georgia Vogelsang (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

Sign-in to see more

All Publications

2009: Vogelsang Georgia B
Magic bullet, part III?
Blood 2009;114(3):498-9.
2008: Griffith Linda M; Pavletic Steven Z; Lee Stephanie J; Martin Paul J; Schultz Kirk R; Vogelsang Georgia B
Chronic Graft-versus-Host Disease--implementation of the National Institutes of Health Consensus Criteria for Clinical Trials.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2008;14(4):379-84.
2008: Bolaños-Meade Javier; Vogelsang Georgia B
Chronic graft-versus-host disease.
Current pharmaceutical design 2008;14(20):1974-86.
2007: Bolaños-Meade Javier; Garrett-Mayer Elizabeth; Luznik Leo; Anders Viki; Webb Jennifer; Fuchs Ephraim J; Huff Carol Ann; Matsui William; Borrello Ivan M; Brodsky Robert; Kasamon Yvette L; Swinnen Lode J; Flinn Ian W; Ambinder Richard F; Jones Richard J; Hess Allan D; Vogelsang Georgia B
Induction of autologous graft-versus-host disease: results of a randomized prospective clinical trial in patients with poor risk lymphoma.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2007;13(10):1185-91.
2007: Jacobsohn David A; Chen Allen R; Zahurak Marianna; Piantadosi Steven; Anders Viki; Bolaños-Meade Javier; Higman Meghan; Margolis Jeffrey; Kaup Michele; Vogelsang Georgia B
Phase II study of pentostatin in patients with corticosteroid-refractory chronic graft-versus-host disease.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2007;25(27):4255-61.
2007: Nevo Shoshan; Fuller Alice K; Zahurak Marianna L; Hartley Eric; Borinsky Mark E; Vogelsang Georgia B
Profound thrombocytopenia and survival of hematopoietic stem cell transplant patients without clinically significant bleeding, using prophylactic platelet transfusion triggers of 10 x 10(9) or 20 x 10(9) per L.
Transfusion 2007;47(9):1700-9.
2007: Bolaños-Meade Javier; Anders Viki; Wisell Joshua; Farmer Evan R; Vogelsang Georgia B
Grover's Disease after Bone Marrow Transplantation.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2007;13(9):1116-7.
2007: Nevo Shoshan; Fuller Alice K; Hartley Eric; Borinsky Mark E; Vogelsang Georgia B
Acute bleeding complications in patients after hematopoietic stem cell transplantation with prophylactic platelet transfusion triggers of 10 x 10(9) and 20 x 10(9) per L.
Transfusion 2007;47(5):801-12.
2007: Bolaños-Meade Javier; Vogelsang Georgia B
Montelukast in chronic graft-versus-host disease: a breath of fresh air?
Transplantation 2007;83(5):527-8.
2007: Jacobsohn David A; Vogelsang Georgia B
Acute graft versus host disease.
Orphanet journal of rare diseases 2007;2():35.
2006: Pavletic S Z; Lee S J; Socie G; Vogelsang G
Chronic graft-versus-host disease: implications of the National Institutes of Health consensus development project on criteria for clinical trials.
Bone marrow transplantation 2006;38(10):645-51.
2006: Bolaños-Meade Javier; Vogelsang Georgia B
Mesenchymal stem cells and organ transplantation: current status and promising future.
Transplantation 2006;81(10):1388-9.
2006: Martin Paul J; Weisdorf Daniel; Przepiorka Donna; Hirschfeld Steven; Farrell Ann; Rizzo J Douglas; Foley Ronan; Socie Gerard; Carter Shelly; Couriel Daniel; Schultz Kirk R; Flowers Mary E D; Filipovich Alexandra H; Saliba Rima; Vogelsang Georgia B; Pavletic Steven Z; Lee Stephanie J;
National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: VI. Design of Clinical Trials Working Group report.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2006;12(5):491-505.
2006: Huff Carol Ann; Fuchs Ephraim J; Smith B Douglas; Blackford Amanda; Garrett-Mayer Elizabeth; Brodsky Robert A; Flinn Ian W; Ambinder Richard F; Borrello Ivan M; Matsui William H; Vogelsang Georgia B; Griffin Constance A; Luznik Leo; Jones Richard J
Graft-versus-host reactions and the effectiveness of donor lymphocyte infusions.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2006;12(4):414-21.
2006: Couriel Daniel; Carpenter Paul A; Cutler Corey; Bolaños-Meade Javier; Treister Nathaniel S; Gea-Banacloche Juan; Shaughnessy Paul; Hymes Sharon; Kim Stella; Wayne Alan S; Chien Jason W; Neumann Joyce; Mitchell Sandra; Syrjala Karen; Moravec Carina K; Abramovitz Linda; Liebermann Jerry; Berger Ann; Gerber Lynn; Schubert Mary; Filipovich Alexandra H; Weisdorf Daniel; Schubert Mark M; Shulman Howard; Schultz Kirk; Mittelman Barbara; Pavletic Steven; Vogelsang Georgia B; Martin Paul J; Lee Stephanie J; Flowers Mary E D
Ancillary therapy and supportive care of chronic graft-versus-host disease: national institutes of health consensus development project on criteria for clinical trials in chronic Graft-versus-host disease: V. Ancillary Therapy and Supportive Care Working Group Report.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2006;12(4):375-96.
2006: Pavletic Steven Z; Martin Paul; Lee Stephanie J; Mitchell Sandra; Jacobsohn David; Cowen Edward W; Turner Maria L; Akpek Gorgun; Gilman Andrew; McDonald George; Schubert Mark; Berger Ann; Bross Peter; Chien Jason W; Couriel Daniel; Dunn J P; Fall-Dickson Jane; Farrell Ann; Flowers Mary E D; Greinix Hildegard; Hirschfeld Steven; Gerber Lynn; Kim Stella; Knobler Robert; Lachenbruch Peter A; Miller Frederick W; Mittleman Barbara; Papadopoulos Esperanza; Parsons Susan K; Przepiorka Donna; Robinson Michael; Ward Michael; Reeve Bryce; Rider Lisa G; Shulman Howard; Schultz Kirk R; Weisdorf Daniel; Vogelsang Georgia B;
Measuring therapeutic response in chronic graft-versus-host disease: National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: IV. Response Criteria Working Group report.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2006;12(3):252-66.
2006: Schultz Kirk R; Miklos David B; Fowler Daniel; Cooke Ken; Shizuru Judith; Zorn Emmanuel; Holler Ernst; Ferrara James; Shulman Howard; Lee Stephanie J; Martin Paul; Filipovich Alexandra H; Flowers Mary E D; Weisdorf Daniel; Couriel Daniel; Lachenbruch Peter A; Mittleman Barbara; Vogelsang Georgia B; Pavletic Steven Z
Toward biomarkers for chronic graft-versus-host disease: National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: III. Biomarker Working Group Report.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2006;12(2):126-37.
2006: Shulman Howard M; Kleiner David; Lee Stephanie J; Morton Thomas; Pavletic Steven Z; Farmer Evan; Moresi J Margaret; Greenson Joel; Janin Anne; Martin Paul J; McDonald George; Flowers Mary E D; Turner Maria; Atkinson Jane; Lefkowitch Jay; Washington M Kay; Prieto Victor G; Kim Stella K; Argenyi Zsolt; Diwan A Hafeez; Rashid Asif; Hiatt Kim; Couriel Dan; Schultz Kirk; Hymes Sharon; Vogelsang Georgia B
Histopathologic diagnosis of chronic graft-versus-host disease: National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: II. Pathology Working Group Report.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2006;12(1):31-47.
2005: Filipovich Alexandra H; Weisdorf Daniel; Pavletic Steven; Socie Gerard; Wingard John R; Lee Stephanie J; Martin Paul; Chien Jason; Przepiorka Donna; Couriel Daniel; Cowen Edward W; Dinndorf Patricia; Farrell Ann; Hartzman Robert; Henslee-Downey Jean; Jacobsohn David; McDonald George; Mittleman Barbara; Rizzo J Douglas; Robinson Michael; Schubert Mark; Schultz Kirk; Shulman Howard; Turner Maria; Vogelsang Georgia; Flowers Mary E D
National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. Diagnosis and staging working group report.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2005;11(12):945-56.
2005: Neuman D L; Farrar J E; Moresi J M; Vogelsang G B; Higman M A
Toxic absorption of tacrolimus [corrected] in a patient with severe acute graft-versus-host disease.
Bone marrow transplantation 2005;36(10):919-20.
2005: Wu Julie M; Bensen-Kennedy Debra; Miura Yuji; Thoburn Christopher J; Armstrong Deborah; Vogelsang Georgia B; Hess Allan D
The effects of interleukin 10 and interferon gamma cytokine gene polymorphisms on survival after autologous bone marrow transplantation for patients with breast cancer.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2005;11(6):455-64.
2005: Bolaños-Meade Javier; Ioffe Olga; Hey Jamie C; Vogelsang Georgia B; Akpek Görgün
Lymphocytic pneumonitis as the manifestation of acute graft-versus-host disease of the lung.
American journal of hematology 2005;79(2):132-5.
2005: Nanda A; Rizzo J D; Vogelsang G B
A case of retroperitoneal fibrosis in a patient following HSCT.
Bone marrow transplantation 2005;35(11):1125-6.
2005: Bolaños-Meade Javier; Jacobsohn David A; Margolis Jeffrey; Ogden Adam; Wientjes M Guillaume; Byrd John C; Lucas David M; Anders Viki; Phelps Michele; Grever Michael R; Vogelsang Georgia B
Pentostatin in steroid-refractory acute graft-versus-host disease.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(12):2661-8.
2005: Bolaños-Meade Javier; Zhou Lan; Hoke Ahmet; Corse Andrea; Vogelsang Georgia; Wagner Kathryn R
Hydroxychloroquine causes severe vacuolar myopathy in a patient with chronic graft-versus-host disease.
American journal of hematology 2005;78(4):306-9.
2005: Goldberg Jenna; Jacobsohn David A; Zahurak Marianna L; Vogelsang Georgia B
Gastrointestinal toxicity from the preparative regimen is associated with an increased risk of graft-versus-host disease.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2005;11(2):101-7.
2005: Bolaños-Meade Javier; Vogelsang Georgia B
Novel strategies for steroid-refractory acute graft-versus-host disease.
Current opinion in hematology 2005;12(1):40-4.
2004: Higman Meghan; Vogelsang Georgia B; Chen Allen
Pentostatin - pharmacology, immunology, and clinical effects in graft-versus-host disease.
Expert opinion on pharmacotherapy 2004;5(12):2605-13.
2004: Mullally Ann M; Vogelsang Georgia B; Moliterno Alison R
Wasted sheep and premature infants: the role of trace metals in hematopoiesis.
Blood reviews 2004;18(4):227-34.
2004: Bolaños-Meade Javier; Vogelsang Georgia B
Acute graft-versus-host disease.
Clinical advances in hematology & oncology : H&O 2004;2(10):672-82.
2004: Miura Yuji; Thoburn Christopher J; Bright Emilie C; Phelps Michele L; Shin Tahiro; Matsui Elizabeth C; Matsui William H; Arai Sally; Fuchs Ephraim J; Vogelsang Georgia B; Jones Richard J; Hess Allan D
Association of Foxp3 regulatory gene expression with graft-versus-host disease.
Blood 2004;104(7):2187-93.
2004: Kuo Irene C; Kempen John H; Dunn James P; Vogelsang Georgia; Jabs Douglas A
Clinical characteristics and outcomes of cytomegalovirus retinitis in persons without human immunodeficiency virus infection.
American journal of ophthalmology 2004;138(3):338-46.
2004: Wolff D; Anders V; Corio R; Horn T; Morison W L; Farmer E; Vogelsang G B
Oral PUVA and topical steroids for treatment of oral manifestations of chronic graft-vs.-host disease.
Photodermatology, photoimmunology & photomedicine 2004;20(4):184-90.
2004: Higman Meghan A; Vogelsang Georgia B
Chronic graft versus host disease.
British journal of haematology 2004;125(4):435-54.
2004: Jacobsohn David A; Vogelsang Georgia B
Anti-cytokine therapy for the treatment of graft-versus-host disease.
Current pharmaceutical design 2004;10(11):1195-205.
2003: Jacobsohn David A; Hallick Jason; Anders Viki; McMillan Stephanie; Morris Lawrence; Vogelsang Georgia B
Infliximab for steroid-refractory acute GVHD: a case series.
American journal of hematology 2003;74(2):119-24.
2003: Flowers Mary E D; Lee Stephanie; Vogelsang Georgia
An update on how to treat chronic GVHD.
Blood 2003;102(6):2312.
2003: Song D Y; Jones R J; Welsh J S; Haulk T L; Korman L T; Noga S; Goodman S; Herman M; Mann R; Marcellus D; Vogelsang G; Ambinder R F; Abrams R A
Phase I study of escalating doses of low-dose-rate, locoregional irradiation preceding Cytoxan-TBI for patients with chemotherapy-resistant non-Hodgkin's or Hodgkin's lymphoma.
International journal of radiation oncology, biology, physics 2003;57(1):166-71.
2003: Flowers Mary E D; Lee Stephanie; Vogelsang Georgia
Re: chronic graft-versus-host disease.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2003;9(8):540.
2003: Akpek Gorgun; Lee Stephanie J; Flowers Mary E; Pavletic Steven Z; Arora Mukta; Lee Shing; Piantadosi Steven; Guthrie Katherine A; Lynch James C; Takatu Alessandra; Horowitz Mary M; Antin Joseph H; Weisdorf Daniel J; Martin Paul J; Vogelsang Georgia B
Performance of a new clinical grading system for chronic graft-versus-host disease: a multicenter study.
Blood 2003;102(3):802-9.
2003: Goldberg Jenna D; Jacobsohn David A; Margolis Jeffrey; Chen Allen R; Anders Viki; Phelps Michele; Vogelsang Georgia B
Pentostatin for the treatment of chronic graft-versus-host disease in children.
Journal of pediatric hematology/oncology : official journal of the American Society of Pediatric Hematology/Oncology 2003;25(7):584-8.
2003: McDonough C H; Jacobsohn D A; Vogelsang G B; Noga S J; Chen A R
High incidence of graft failure in children receiving CD34+ augmented elutriated allografts for nonmalignant diseases.
Bone marrow transplantation 2003;31(12):1073-80.
2003: Huff Carol Ann; Fuchs Ephraim J; Noga Stephen J; O'Donnell Paul V; Ambinder Richard F; Diehl Louis; Borrello Ivan; Vogelsang Georgia B; Miller Carole B; Flinn Ian A; Brodsky Robert A; Marcellus Deborah; Jones Richard J
Long-term follow-up of T cell-depleted allogeneic bone marrow transplantation in refractory multiple myeloma: importance of allogeneic T cells.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2003;9(5):312-9.
2003: Lee Stephanie J; Vogelsang Georgia; Flowers Mary E D
Chronic graft-versus-host disease.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2003;9(4):215-33.
2003: Mezey Eva; Key Sharon; Vogelsang Georgia; Szalayova Ildiko; Lange G David; Crain Barbara
Transplanted bone marrow generates new neurons in human brains.
Proceedings of the National Academy of Sciences of the United States of America 2003;100(3):1364-9.
2003: Akpek Görgün; Chinratanalab Wichai; Lee Linda A; Torbenson Michael; Hallick Jason P; Anders Viki; Vogelsang Georgia B
Gastrointestinal involvement in chronic graft-versus-host disease: a clinicopathologic study.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2003;9(1):46-51.
2003: Vogelsang Georgia B; Lee Linda; Bensen-Kennedy Debra M
Pathogenesis and treatment of graft-versus-host disease after bone marrow transplant.
Annual review of medicine 2003;54():29-52.
2002: Chaudhry V; Cornblath D R; Corse A; Freimer M; Simmons-O'Brien E; Vogelsang G
Thalidomide-induced neuropathy.
Neurology 2002;59(12):1872-5.
2002: Vogelsang Georgia B; Dalal Jignesh
Hepatic venoocclusive disease in blood and bone marrow transplantation in children: incidence, risk factors, and outcome.
Journal of pediatric hematology/oncology : official journal of the American Society of Pediatric Hematology/Oncology 2002;24(9):706-9.
2002: Akpek Görgün; Boitnott John K; Lee Linda A; Hallick Jason P; Torbenson Michael; Jacobsohn David A; Arai Sally; Anders Viki; Vogelsang Georgia B
Hepatitic variant of graft-versus-host disease after donor lymphocyte infusion.
Blood 2002;100(12):3903-7.
2002: Richardson Paul G; Murakami Carol; Jin Zhezhen; Warren Diane; Momtaz Parisa; Hoppensteadt Deborah; Elias Anthony D; Antin Joseph H; Soiffer Robert; Spitzer Thomas; Avigan David; Bearman Scott I; Martin Paul L; Kurtzberg Joanne; Vredenburgh James; Chen Allen R; Arai Sally; Vogelsang Georgia; McDonald George B; Guinan Eva C
Multi-institutional use of defibrotide in 88 patients after stem cell transplantation with severe veno-occlusive disease and multisystem organ failure: response without significant toxicity in a high-risk population and factors predictive of outcome.
Blood 2002;100(13):4337-43.
2002: Jacobsohn D A; Ruble K; Moresi J M; Vogelsang G B
Rapid-onset leucodrema associated with graft-versus-host disease.
Bone marrow transplantation 2002;30(10):705-6.
2002: McDonough Colleen H; Lee Linda; de Beur S Jan; Arai Sally; Vogelsang Georgia B
Myxedema ascites in the posttransplant setting: case report.
American journal of hematology 2002;71(3):216-8.
2002: Hsu Jack W; Czander Magalena; Anders Viki; Vogelsang Georgia; Brodsky Robert A
Parvovirus b19-associated pure red cell aplasia in chronic graft-versus-host disease.
British journal of haematology 2002;119(1):280-1.
2002: Cruz-Correa M; Poonawala A; Abraham S C; Wu T T; Zahurak M; Vogelsang G; Kalloo A N; Lee L A
Endoscopic findings predict the histologic diagnosis in gastrointestinal graft-versus-host disease.
Endoscopy 2002;34(10):808-13.
2002: Hsu J W; Vogelsang G; Jones R J; Brodsky R A
Bone marrow transplantation in Shwachman-Diamond syndrome.
Bone marrow transplantation 2002;30(4):255-8.
2002: Smith B Douglas; Jones Richard J; Lee Shing M; Piantadosi Steve; Vala Milada S; Fuller Don; Gore Steven D; Noga Steven J; O'Donnell Paul V; Braine Hayden; Vogelsang Georgia B; Fuchs Ephraim J; Flinn Ian W; Brodsky Robert A; Ambinder Richard F; Miller Carole B
Autologous bone marrow transplantation with 4-hydroperoxycyclophosphamide purging for acute myeloid leukaemia beyond first remission: a 10-year experience.
British journal of haematology 2002;117(4):907-13.
2002: Arai Sally; Lee Linda A; Vogelsang Georgia B
A systematic approach to hepatic complications in hematopoietic stem cell transplantation.
Journal of hematotherapy & stem cell research 2002;11(2):215-29.
2002: Thompson A M; Couch M; Zahurak M L; Johnson C; Vogelsang G B
Risk factors for post-stem cell transplant sinusitis.
Bone marrow transplantation 2002;29(3):257-61.
2002: Jacobsohn D A; Margolis J; Doherty J; Anders V; Vogelsang G B
Weight loss and malnutrition in patients with chronic graft-versus-host disease.
Bone marrow transplantation 2002;29(3):231-6.
2002: Wingard John R; Vogelsang Georgia B; Deeg H Joachim
Stem cell transplantation: supportive care and long-term complications.
Hematology / the Education Program of the American Society of Hematology. American Society of Hematology. Education Program 2002;():422-44.
2002: O'Donnell P V; Luznik L; Jones R J; Vogelsang G B; Leffell M S; Phelps M; Rhubart P; Cowan K; Piantados S; Fuchs E J
Nonmyeloablative bone marrow transplantation from partially HLA-mismatched related donors using posttransplantation cyclophosphamide.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2002;8(7):377-86.
2002: Arai Sally; Margolis Jeffrey; Zahurak Marianna; Anders Viki; Vogelsang Georgia B
Poor outcome in steroid-refractory graft-versus-host disease with antithymocyte globulin treatment.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2002;8(3):155-60.
2002: Jacobsohn David A; Vogelsang Georgia B
Novel pharmacotherapeutic approaches to prevention and treatment of GVHD.
Drugs 2002;62(6):879-89.
2002: Lee Stephanie J; Vogelsang Georgia; Gilman Andrew; Weisdorf Daniel J; Pavletic Steven; Antin Joseph H; Horowitz Mary M; Akpek Gorgun; Flowers Mary E; Couriel Daniel; Martin Paul J
A survey of diagnosis, management, and grading of chronic GVHD.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2002;8(1):32-9.
2001: Jacobsohn D A; Montross S; Anders V; Vogelsang G B
Clinical importance of confirming or excluding the diagnosis of chronic graft-versus-host disease.
Bone marrow transplantation 2001;28(11):1047-51.
2001: Akpek G; Ambinder R F; Piantadosi S; Abrams R A; Brodsky R A; Vogelsang G B; Zahurak M L; Fuller D; Miller C B; Noga S J; Fuchs E; Flinn I W; O'Donnell P; Seifter E J; Mann R B; Jones R J
Long-term results of blood and marrow transplantation for Hodgkin's lymphoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2001;19(23):4314-21.
2001: Nevo S; Vogelsang G B
Acute bleeding complications in patients after bone marrow transplantation.
Current opinion in hematology 2001;8(5):319-25.
2001: Vogelsang G B; Arai S
Mycophenolate mofetil for the prevention and treatment of graft-versus-host disease following stem cell transplantation: preliminary findings.
Bone marrow transplantation 2001;27(12):1255-62.
2001: Akpek G; Zahurak M L; Piantadosi S; Margolis J; Doherty J; Davidson R; Vogelsang G B
Development of a prognostic model for grading chronic graft-versus-host disease.
Blood 2001;97(5):1219-26.
2001: Vogelsang G B
How I treat chronic graft-versus-host disease.
Blood 2001;97(5):1196-201.
2001: Leffell M S; Vogelsang G B; Lucas D P; Delaney N L; Zachary A A
Association between TGF-beta expression and severe GVHD in allogeneic bone marrow transplantation.
Transplantation proceedings 2001;33(1-2):485-6.
2001: Akpek G; Valladares J L; Lee L; Margolis J; Vogelsang G B
Pancreatic insufficiency in patients with chronic graft-versus-host disease.
Bone marrow transplantation 2001;27(2):163-6.
2001: Nevo S; Enger C; Hartley E; Borinsky M E; Swan V; Fuller A K; Braine H G; Kickler T S; George J N; Vogelsang G B
Acute bleeding and thrombocytopenia after bone marrow transplantation.
Bone marrow transplantation 2001;27(1):65-72.
2001: Noga S J; Vogelsang G B; Miller S C; Meusel S; Loper K; Case R; Myers B; Rogers L; Flinn I; Borowitz M; O'Donnell P
Using point-of-care CD34 enumeration to optimize PBSC collection conditions.
Cytotherapy 2001;3(1):11-8.
2001: Arai S; Allan C; Streiff M; Hutchins G M; Vogelsang G B; Tsai H M
Von Willebrand factor-cleaving protease activity and proteolysis of von Willebrand factor in bone marrow transplant-associated thrombotic microangiopathy.
The hematology journal : the official journal of the European Haematology Association / EHA 2001;2(5):292-9.
2001: Berdeja J G; Jones R J; Zahurak M L; Piantadosi S; Abrams R A; Borowitz M J; Vogelsang G B; Noga S J; Ambinder R F; Flinn I W
Allogeneic bone marrow transplantation in patients with sensitive low-grade lymphoma or mantle cell lymphoma.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2001;7(10):561-7.
2001: Akpek G; Lee S M; Anders V; Vogelsang G B
A high-dose pulse steroid regimen for controlling active chronic graft-versus-host disease.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2001;7(9):495-502.
2000: Arai S; Vogelsang G B
Management of graft-versus-host disease.
Blood reviews 2000;14(4):190-204.
2000: van der Wall E; Horn T; Bright E; Passos-Coehlo J L; Bond S; Clarke B; Altomonte V; McIntyre K; Vogelsang G; Noga S J; Davis J M; Thomassen J; Ohly K V; Lee S M; Fetting J; Armstrong D K; Davidson N E; Hess A D; Kennedy M J
Autologous graft-versus-host disease induction in advanced breast cancer: role of peripheral blood progenitor cells.
British journal of cancer 2000;83(11):1405-11.
2000: Flinn I W; Byrd J C; Morrison C; Jamison J; Diehl L F; Murphy T; Piantadosi S; Seifter E; Ambinder R F; Vogelsang G; Grever M R
Fludarabine and cyclophosphamide with filgrastim support in patients with previously untreated indolent lymphoid malignancies.
Blood 2000;96(1):71-5.
2000: Margolis J; Vogelsang G
Chronic graft-versus-host disease.
Journal of hematotherapy & stem cell research 2000;9(3):339-46.
2000: Margolis J; Vogelsang G
An old drug for a new disease: pentostatin (Nipent) in acute graft-versus-host disease.
Seminars in oncology 2000;27(2 Suppl 5):72-7.
2000: Vogelsang G B
Advances in the treatment of graft-versus-host disease.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 2000;14(3):509-10.
2000: Flinn I W; O'Donnell P V; Goodrich A; Vogelsang G; Abrams R; Noga S; Marcellus D; Borowitz M; Jones R; Ambinder R F
Immunotherapy with rituximab during peripheral blood stem cell transplantation for non-Hodgkin's lymphoma.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2000;6(6):628-32.
1999: Rizzo J D; Vogelsang G B; Krumm S; Frink B; Mock V; Bass E B
Outpatient-based bone marrow transplantation for hematologic malignancies: cost saving or cost shifting?
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1999;17(9):2811-8.
1999: Vogelsang G; Bitton R; Piantadosi S; Altomonte V; Horn T; Jones R; Miller C; Marcellus D; Abrams R; Hess A
Immune modulation in autologous bone marrow transplantation: cyclosporine and gamma-interferon trial.
Bone marrow transplantation 1999;24(6):637-40.
1999: Mookerjee B; Altomonte V; Vogelsang G
Salvage therapy for refractory chronic graft-versus-host disease with mycophenolate mofetil and tacrolimus.
Bone marrow transplantation 1999;24(5):517-20.
1999: Nevo S; Enger C; Swan V; Wojno K J; Fuller A K; Altomonte V; Braine H G; Noga S J; Vogelsang G B
Acute bleeding after allogeneic bone marrow transplantation: association with graft versus host disease and effect on survival.
Transplantation 1999;67(5):681-9.
1999: Marcellus D C; Altomonte V L; Farmer E R; Horn T D; Freemer C S; Grant J; Vogelsang G B
Etretinate therapy for refractory sclerodermatous chronic graft-versus-host disease.
Blood 1999;93(1):66-70.
1998: O'Donnell P V; Jones R J; Vogelsang G B; Seber A; Ambinder R F; Flinn I; Miller C; Marcellus D C; Griffin C; Abrams R; Braine H G; Grever M; Hess A D; Piantadosi S; Noga S J
CD34+ stem cell augmentation of elutriated allogeneic bone marrow grafts: results of a phase II clinical trial of engraftment and graft-versus-host disease prophylaxis in high-risk hematologic malignancies.
Bone marrow transplantation 1998;22(10):947-55.
1998: Fuchs E J; Seber A; Altomonte V; Braine H G; Humphrey R L; Jones R J; Noga S J; Schepers K; Wright S K; Vogelsang G B
Chemotherapy does not nullify the ability of donor lymphocyte infusions to mediate graft-versus-host reactions.
Bone marrow transplantation 1998;22(3):303-5.
1998: Noga S J; Seber A; Davis J M; Berenson R J; Vogelsang G B; Braine H G; Hess A D; Marcellus D; Miller C A; Sharkis S J; Goodman S N; Santos G W; Jones R J
CD34 augmentation improves allogeneic T cell-depleted bone marrow engraftment.
Journal of hematotherapy 1998;7(2):151-7.
1998: Flinn I W; Vogelsang G
Bone marrow transplantation for chronic lymphocytic leukemia.
Seminars in oncology 1998;25(1):60-4.
1998: Nevo S; Swan V; Enger C; Wojno K J; Bitton R; Shabooti M; Fuller A K; Jones R J; Braine H G; Vogelsang G B
Acute bleeding after bone marrow transplantation (BMT)- incidence and effect on survival. A quantitative analysis in 1,402 patients.
Blood 1998;91(4):1469-77.
1997: Mookerjee B P; Vogelsang G
Human herpes virus-6 encephalitis after bone marrow transplantation: successful treatment with ganciclovir.
Bone marrow transplantation 1997;20(10):905-6.
1997: Zachary A A; Vogelsang G B; Steinberg A G; Leffell M S
Strategies for determining HLA compatibility in related donor bone marrow transplantation.
Transplantation 1997;64(6):828-35.
1997: Horn T D; Zahurak M L; Atkins D; Solomon A R; Vogelsang G B
Lichen planus-like histopathologic characteristics in the cutaneous graft-vs-host reaction. Prognostic significance independent of time course after allogeneic bone marrow transplantation.
Archives of dermatology 1997;133(8):961-5.
1997: Marcellus D C; Vogelsang G B
Graft-versus-host disease.
Current opinion in oncology 1997;9(2):131-8.
1997: Lazarus H M; Vogelsang G B; Rowe J M
Prevention and treatment of acute graft-versus-host disease: the old and the new. A report from the Eastern Cooperative Oncology Group (ECOG).
Bone marrow transplantation 1997;19(6):577-600.
1997: Hess A D; Bright E C; Thoburn C; Vogelsang G B; Jones R J; Kennedy M J
Specificity of effector T lymphocytes in autologous graft-versus-host disease: role of the major histocompatibility complex class II invariant chain peptide.
Blood 1997;89(6):2203-9.
1997: Noga S J; Vogelsang G B; Seber A; Davis J M; Schepers K; Hess A D; Jones R J
CD34+ stem cell augmentation of allogeneic, elutriated marrow grafts improves engraftment but cyclosporine A is still required to reduce GVHD and morbidity.
Transplantation proceedings 1997;29(1-2):728-32.
1997: Vogelsang G B
Graft-versus-host disease: implications from basic immunology for prophylaxis and treatment.
Cancer treatment and research 1997;77():87-97.
1996: Fox R J; Vogelsang G B; Beschorner W E
Denuded bowel after recovery from graft-versus-host disease.
Transplantation 1996;62(11):1681-4.
1996: Vogelsang G B; Wolff D; Altomonte V; Farmer E; Morison W L; Corio R; Horn T
Treatment of chronic graft-versus-host disease with ultraviolet irradiation and psoralen (PUVA).
Bone marrow transplantation 1996;17(6):1061-7.
1996: Miller C B; Piantadosi S; Vogelsang G B; Marcellus D C; Grochow L; Kennedy M J; Jones R J
Impact of age on outcome of patients with cancer undergoing autologous bone marrow transplant.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1996;14(4):1327-32.
1996: Horn T D; Altomonte V; Vogelsang G; Kennedy M J
Erythroderma after autologous bone marrow transplantation modified by administration of cyclosporine and interferon gamma for breast cancer.
Journal of the American Academy of Dermatology 1996;34(3):413-7.
1996: Goulmy E; Schipper R; Pool J; Blokland E; Falkenburg J H; Vossen J; Gratwohl A; Vogelsang G B; van Houwelingen H C; van Rood J J
Mismatches of minor histocompatibility antigens between HLA-identical donors and recipients and the development of graft-versus-host disease after bone marrow transplantation.
The New England journal of medicine 1996;334(5):281-5.
1995: Hess A D; Kennedy M J; Ruvolo P P; Vogelsang G B; Jones R J
Antitumor activity of syngeneic/autologous graft-versus-host disease.
Annals of the New York Academy of Sciences 1995;770():189-202.
1995: Horn T D; Rest E B; Mirenski Y; Corio R L; Zahurak M L; Vogelsang G B
The significance of oral mucosal and salivary gland pathology after allogeneic bone marrow transplantation.
Archives of dermatology 1995;131(8):964-5.
1995: Ruvolo P P; Fischer A C; Vogelsang G B; Jones R J; Hess A D
Analysis of the V beta T-cell receptor repertoire in autologous graft-versus-host disease.
Annals of the New York Academy of Sciences 1995;756():432-4.
1995: Martin R W; Farmer E R; Altomonte V L; Vogelsang G B; Santos G W
Lichenoid graft-vs-host disease in an autologous bone marrow transplant recipient.
Archives of dermatology 1995;131(3):333-5.
1995: Ruvolo P; Bright E; Kennedy M J; Morris L; Fischer A; Vogelsang G; Jones R; Hess A
Cyclosporine-induced autologous graft versus host disease: assessment of cytolytic effector mechanisms and the V beta T-cell receptor repertoire.
Transplantation proceedings 1995;27(1):1363-5.
1995: Uthoff K; Zehr K J; Gaudin P B; Kumar P; Cho P W; Vogelsang G; Hruban R H; Baumgartner W A; Stuart R S
Thalidomide as replacement for steroids in immunosuppression after lung transplantation.
The Annals of thoracic surgery 1995;59(2):277-82.
1994: Vogelsang G B; Hess A D
Graft-versus-host disease: new directions for a persistent problem.
Blood 1994;84(7):2061-7.
1994: Horn T D; Bauer D J; Vogelsang G B; Hess A D
Reappraisal of histologic features of the acute cutaneous graft-versus-host reaction based on an allogeneic rodent model.
The Journal of investigative dermatology 1994;103(2):206-10.
1994: Coskuncan N M; Jabs D A; Dunn J P; Haller J A; Green W R; Vogelsang G B; Santos G W
The eye in bone marrow transplantation. VI. Retinal complications.
Archives of ophthalmology 1994;112(3):372-9.
1994: Kennedy M J; Vogelsang G B; Jones R J; Farmer E R; Hess A D; Altomonte V; Huelskamp A M; Davidson N E
Phase I trial of interferon gamma to potentiate cyclosporine-induced graft-versus-host disease in women undergoing autologous bone marrow transplantation for breast cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1994;12(2):249-57.
1994: Wojno K J; Vogelsang G B; Beschorner W E; Santos G W
Pulmonary hemorrhage as a cause of death in allogeneic bone marrow recipients with severe acute graft-versus-host disease.
Transplantation 1994;57(1):88-92.
1994: Freemer C S; Farmer E R; Corio R L; Altomonte V L; Wagner J E; Vogelsang G B; Santos G W
Lichenoid chronic graft-vs-host disease occurring in a dermatomal distribution.
Archives of dermatology 1994;130(1):70-2.
1993: Yeager A M; Vogelsang G B; Jones R J; Farmer E R; Hess A D; Santos G W
Cyclosporine-induced graft-versus-host disease after autologous bone marrow transplantation for acute myeloid leukemia.
Leukemia & lymphoma 1993;11(3-4):215-20.
1993: Dunn J P; Jabs D A; Wingard J; Enger C; Vogelsang G; Santos G
Bone marrow transplantation and cataract development.
Archives of ophthalmology 1993;111(10):1367-73.
1993: May W S; Sensenbrenner L L; Burns W H; Ambinder R; Carroll M P; Griffin C A; Jones R J; Miller C B; Mellits E D; Vogelsang G B
BMT for severe aplastic anemia using cyclosporine.
Bone marrow transplantation 1993;11(6):459-64.
1993: Vogelsang G B; Morris L E
Prevention and management of graft-versus-host disease. Practical recommendations.
Drugs 1993;45(5):668-76.
1993: Vogelsang G B
Acute and chronic graft-versus-host disease.
Current opinion in oncology 1993;5(2):276-81.
1993: Kennedy M J; Vogelsang G B; Beveridge R A; Farmer E R; Altomonte V; Huelskamp A M; Davidson N E
Phase I trial of intravenous cyclosporine to induce graft-versus-host disease in women undergoing autologous bone marrow transplantation for breast cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1993;11(3):478-84.
1993: Vogelsang G B; Hess A D
Rapamycin effects on immunologic reconstitution.
Transplantation proceedings 1993;25(1 Pt 1):727-8.
1992: Darmstadt G L; Donnenberg A D; Vogelsang G B; Farmer E R; Horn T D
Clinical, laboratory, and histopathologic indicators of the development of progressive acute graft-versus-host disease.
The Journal of investigative dermatology 1992;99(4):397-402.
1992: Hess A D; Jones R J; Morris L E; Noga S J; Vogelsang G B; Santos G W
Autologous graft-versus-host disease: a novel approach for antitumor immunotherapy.
Human immunology 1992;34(3):219-24.
1992: Krenn M; Gamcsik M P; Vogelsang G B; Colvin O M; Leong K W
Improvements in solubility and stability of thalidomide upon complexation with hydroxypropyl-beta-cyclodextrin.
Journal of pharmaceutical sciences 1992;81(7):685-9.
1992: Yeager A M; Vogelsang G B; Jones R J; Farmer E R; Altomonte V; Hess A D; Santos G W
Induction of cutaneous graft-versus-host disease by administration of cyclosporine to patients undergoing autologous bone marrow transplantation for acute myeloid leukemia.
Blood 1992;79(11):3031-5.
1992: Wagner J E; Zahurak M; Piantadosi S; Geller R B; Vogelsang G B; Wingard J R; Saral R; Griffin C; Shah N; Zehnbauer B A
Bone marrow transplantation of chronic myelogenous leukemia in chronic phase: evaluation of risks and benefits.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1992;10(5):779-89.
1992: Vogelsang G B; Farmer E R; Hess A D; Altamonte V; Beschorner W E; Jabs D A; Corio R L; Levin L S; Colvin O M; Wingard J R
Thalidomide for the treatment of chronic graft-versus-host disease.
The New England journal of medicine 1992;326(16):1055-8.
1992: Wagner J E; Vogelsang G B; Zehnbauer B A; Griffin C A; Shah N; Santos G W
Relapse of leukemia after bone marrow transplantation: effect of second myeloablative therapy.
Bone marrow transplantation 1992;9(3):205-9.
1992: Hess A D; Jones R J; Morris L E; Noga S J; Yeager A M; Vogelsang G B; Santos G W
Autologous graft-versus-host disease: a new frontier in immunotherapy.
Bone marrow transplantation 1992;10 Suppl 1():16-21.
1992: Noga S J; Davis J M; Vogelsang G B; Donnenberg A D; Thoburn C; Schepers K; Sproul J
The combined use of elutriation and CD8/magnetic bead separation to engineer the bone marrow allograft.
Progress in clinical and biological research 1992;377():411-8.
1991: Horn T D; Rest E B; Karp J E; Burke P J; Vogelsang G B; Boucher C L; Hood A F
Interleukin 2 and granulocyte-macrophage colony-stimulating factor induce a perivascular lymphocytic infiltrate in a skin explant model.
Archives of dermatology 1991;127(12):1789-93.
1991: Jampel R M; Farmer E R; Vogelsang G B; Wingard J; Santos G W; Morison W L
PUVA therapy for chronic cutaneous graft-vs-host disease.
Archives of dermatology 1991;127(11):1673-8.
1991: Carbone K M; Park S W; Rubin S A; Waltrip R W; Vogelsang G B
Borna disease: association with a maturation defect in the cellular immune response.
Journal of virology 1991;65(11):6154-64.
1991: Keenan R J; Eiras G; Burckart G J; Stuart R S; Hardesty R L; Vogelsang G; Griffith B P; Zeevi A
Immunosuppressive properties of thalidomide. Inhibition of in vitro lymphocyte proliferation alone and in combination with cyclosporine or FK506.
Transplantation 1991;52(5):908-10.
1991: Avery R; Jabs D A; Wingard J R; Vogelsang G; Saral R; Santos G
Optic disc edema after bone marrow transplantation. Possible role of cyclosporine toxicity.
Ophthalmology 1991;98(8):1294-301.
1991: Funkhouser A W; Vogelsang G; Zehnbauer B; Tunnessen W W; Beschorner W E; Sanders M; Graeber J E
Graft versus host disease after blood transfusions in a premature infant.
Pediatrics 1991;87(2):247-50.
1990: Vogelsang G B; Wagner J E
Graft-versus-host disease.
Hematology/oncology clinics of North America 1990;4(3):625-39.
1990: Vogelsang G B
Graft-versus-host disease.
Current opinion in oncology 1990;2(2):285-8.
1990: Wagner J E; Santos G W; Noga S J; Rowley S D; Davis J; Vogelsang G B; Farmer E R; Zehnbauer B A; Saral R; Donnenberg A D
Bone marrow graft engineering by counterflow centrifugal elutriation: results of a phase I-II clinical trial.
Blood 1990;75(6):1370-7.
1990: Vogelsang G B
Transfusion-associated graft-versus-host disease in nonimmunocompromised hosts.
Transfusion 1990;30(2):101-3.
1990: Tamura F; Vogelsang G B; Reitz B A; Baumgartner W A; Herskowitz A
Combination thalidomide and cyclosporine for cardiac allograft rejection. Comparison with combination methylprednisolone and cyclosporine.
Transplantation 1990;49(1):20-5.
1990: Noga S J; Wagner J E; Rowley S D; Davis J M; Vogelsang G B; Hess A D; Saral R; Santos G W; Donnenberg A D
Using elutriation to engineer bone marrow allografts.
Progress in clinical and biological research 1990;333():345-59; discussion 360-1.
1990: Vogelsang G B
Acute graft-versus-host disease.
Cancer treatment and research 1990;50():55-77.
1989: Holland H K; Saral R; Rossi J J; Donnenberg A D; Burns W H; Beschorner W E; Farzadegan H; Jones R J; Quinnan G V; Vogelsang G B
Allogeneic bone marrow transplantation, zidovudine, and human immunodeficiency virus type 1 (HIV-1) infection. Studies in a patient with non-Hodgkin lymphoma.
Annals of internal medicine 1989;111(12):973-81.
1989: Jabs D A; Wingard J; Green W R; Farmer E R; Vogelsang G; Saral R
The eye in bone marrow transplantation. III. Conjunctival graft-vs-host disease.
Archives of ophthalmology 1989;107(9):1343-8.
1989: Wingard J R; Piantadosi S; Vogelsang G B; Farmer E R; Jabs D A; Levin L S; Beschorner W E; Cahill R A; Miller D F; Harrison D
Predictors of death from chronic graft-versus-host disease after bone marrow transplantation.
Blood 1989;74(4):1428-35.
1989: Vogelsang G B; Hess A D; Friedman K J; Santos G W
Therapy of chronic graft-v-host disease in a rat model.
Blood 1989;74(1):507-11.
1989: Chen T L; Vogelsang G B; Petty B G; Brundrett R B; Noe D A; Santos G W; Colvin O M
Plasma pharmacokinetics and urinary excretion of thalidomide after oral dosing in healthy male volunteers.
Drug metabolism and disposition: the biological fate of chemicals 1989;17(4):402-5.
1989: Horn T D; Farmer E R; Vogelsang G B; Wingard J R; Santos G W
Cutaneous graft-versus-host reaction lacks evidence of cutaneous cytomegalovirus by the immunoperoxidase technique.
The Journal of investigative dermatology 1989;93(1):92-5.
1989: Geller R B; Saral R; Piantadosi S; Zahurak M; Vogelsang G B; Wingard J R; Ambinder R F; Beschorner W B; Braine H G; Burns W H
Allogeneic bone marrow transplantation after high-dose busulfan and cyclophosphamide in patients with acute nonlymphocytic leukemia.
Blood 1989;73(8):2209-18.
1989: Jones R J; Vogelsang G B; Hess A D; Farmer E R; Mann R B; Geller R B; Piantadosi S; Santos G W
Induction of graft-versus-host disease after autologous bone marrow transplantation.
Lancet 1989;1(8641):754-7.
1989: Wells M S; Vogelsang G B; Colombani P M; Hess A D
Cyclosporin A binding to calmodulin.
Transplantation proceedings 1989;21(1 Pt 1):850-2.
1989: Vogelsang G B; Jones R J; Hess A D; Geller R; Schucter L; Santos G W
Induction of autologous graft-versus-host disease.
Transplantation proceedings 1989;21(1 Pt 3):2997-8.
1989: Hopkins K A; Vogelsang G B; Delaney N L; Gullette D L; Santos G W; Bias W B
Implication of a gene distal to HLA-A in the etiology of graft-versus-host disease.
Transplantation proceedings 1989;21(1 Pt 3):2971-3.
1989: Wagner J E; Vogelsang G B; Beschorner W E
Pathogenesis and pathology of graft-vs.-host disease.
The American journal of pediatric hematology/oncology 1989;11(2):196-212.
1988: Geller R B; Vogelsang G B; Wingard J R; Yeager A M; Burns W H; Santos G W; Saral R
Successful marrow transplantation for acute myelocytic leukemia following therapy for Hodgkin's disease.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1988;6(10):1558-61.
1988: Wagner J E; Donnenberg A D; Noga S J; Cremo C A; Gao I K; Yin H J; Vogelsang G B; Rowley S; Saral R; Santos G W
Lymphocyte depletion of donor bone marrow by counterflow centrifugal elutriation: results of a phase I clinical trial.
Blood 1988;72(4):1168-76.
1988: Vogelsang G B; Hess A D; Santos G W
Thalidomide for treatment of graft-versus-host disease.
Bone marrow transplantation 1988;3(5):393-8.
1988: Herman J G; Beschorner W E; Baughman K L; Boitnott J K; Vogelsang G B; Baumgartner W A
Pseudo-graft-versus-host disease in heart and heart-lung recipients.
Transplantation 1988;46(1):93-8.
1988: Hess A D; Vogelsang G B; Silanskis M; Friedman K A; Beschorner W E; Santos G W
Syngeneic graft-versus-host disease after allogeneic bone marrow transplantation and cyclosporine treatment.
Transplantation proceedings 1988;20(3 Suppl 3):487-92.
1988: Vogelsang G B; Hess A D; Santos G W
Acute graft-versus-host disease: clinical characteristics in the cyclosporine era.
Medicine 1988;67(3):163-74.
1988: Vogelsang G B; Wells M C; Santos G W; Chen T L; Hess A D
Combination low-dose thalidomide and cyclosporine prophylaxis for acute graft-versus-host disease in a rat mismatched model.
Transplantation proceedings 1988;20(2 Suppl 2):226-8.
1988: Vogelsang G B; Santos G W; Colvin O M; Chen T
Thalidomide for graft-versus-host disease.
Lancet 1988;1(8589):827.
1988: Burdick J F; Vogelsang G B; Smith W J; Farmer E R; Bias W B; Kaufmann S H; Horn J; Colombani P M; Pitt H A; Perler B A
Severe graft-versus-host disease in a liver-transplant recipient.
The New England journal of medicine 1988;318(11):689-91.
1988: Wagner J E; Donnenberg A D; Noga S J; Wiley J M; Yeager A M; Vogelsang G B; Hess A D; Santos G W
Separation of rat bone marrow cells by counterflow centrifugal elutriation: a model for studying the effects of lymphocyte depletion.
Experimental hematology 1988;16(3):206-12.
1987: Jones R J; Lee K S; Beschorner W E; Vogel V G; Grochow L B; Braine H G; Vogelsang G B; Sensenbrenner L L; Santos G W; Saral R
Venoocclusive disease of the liver following bone marrow transplantation.
Transplantation 1987;44(6):778-83.
1987: Hood A F; Vogelsang G B; Black L P; Farmer E R; Santos G W
Acute graft-vs-host disease. Development following autologous and syngeneic bone marrow transplantation.
Archives of dermatology 1987;123(6):745-50.
1987: Hess A D; Vogelsang G B; Heyd J; Beschorner W E
Cyclosporine-induced syngeneic graft-versus-host disease: assessment of T cell differentiation.
Transplantation proceedings 1987;19(1 Pt 3):2683-6.
1987: Vogelsang G B; Hess A D; Gordon G; Brundrette R; Santos G W
Thalidomide induction of bone marrow transplantation tolerance.
Transplantation proceedings 1987;19(1 Pt 3):2658-61.
1987: Esa A H; Vogelsang G B; Sandford G R; Saral R; Hess A D; Burns W H
Cell-mediated immune responses in rat cytomegalovirus infection.
Transplantation proceedings 1987;19(1 Pt 3):2726-9.
1986: Vogelsang G B; Hess A D; Gordon G; Santos G W
Treatment and prevention of acute graft-versus-host disease with thalidomide in a rat model.
Transplantation 1986;41(5):644-7.
1986: Vogelsang G; Kickler T S; Bell W R
Post-transfusion purpura: a report of five patients and a review of the pathogenesis and management.
American journal of hematology 1986;21(3):259-67.
1985: Santos G W; Hess A D; Vogelsang G B
Graft-versus-host reactions and disease.
Immunological reviews 1985;88():169-92.
1985: Vogelsang G B; Hess A D; Berkman A W; Tutschka P J; Farmer E R; Converse P J; Santos G W
An in vitro predictive test for graft versus host disease in patients with genotypic HLA-identical bone marrow transplants.
The New England journal of medicine 1985;313(11):645-50.
1985: Vogelsang G B; Abeloff M D; Ettinger D S; Booker S V
Long-term survivors of small cell carcinoma of the lung.
The American journal of medicine 1985;79(1):49-56.

Sign-in to see more

Sign-in free and Explore the Exciting World of BiomedExperts:

NetworkView

Georgia Vogelsang

Research Profile (preview)

Disorders

Procedures

Chemicals & Drugs

Concepts & Ideas

Living Beings

Network (preview)

Publications

Sign in free and see...

Visualized networks:

GeoTargeted Searches:

Research Profiles:

Geonetwork of Georgia Vogelsang (preview)

All Publications